NanoCarrier Co. Ltd
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastom… Read more
NanoCarrier Co. Ltd (3NQ) - Total Assets
Latest total assets as of September 2025: €3.38 Billion EUR
Based on the latest financial reports, NanoCarrier Co. Ltd (3NQ) holds total assets worth €3.38 Billion EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NanoCarrier Co. Ltd - Total Assets Trend (2014–2025)
This chart illustrates how NanoCarrier Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NanoCarrier Co. Ltd - Asset Composition Analysis
Current Asset Composition (March 2025)
NanoCarrier Co. Ltd's total assets of €3.38 Billion consist of 90.6% current assets and 9.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 42.7% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €404.00K | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how NanoCarrier Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NanoCarrier Co. Ltd's current assets represent 90.6% of total assets in 2025, an increase from 52.9% in 2014.
- Cash Position: Cash and equivalents constituted 42.7% of total assets in 2025, down from 49.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 0.0% of total assets.
NanoCarrier Co. Ltd Competitors by Total Assets
Key competitors of NanoCarrier Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
NanoCarrier Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NanoCarrier Co. Ltd generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NanoCarrier Co. Ltd is currently not profitable relative to its asset base.
NanoCarrier Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.10 | 8.17 | 35.09 |
| Quick Ratio | 4.10 | 8.17 | 34.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.14 Billion | € 3.72 Billion | € 7.36 Billion |
NanoCarrier Co. Ltd - Advanced Valuation Insights
This section examines the relationship between NanoCarrier Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.69 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -21.2% |
| Total Assets | €4.00 Billion |
| Market Capitalization | $58.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values NanoCarrier Co. Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NanoCarrier Co. Ltd's assets decreased by 21.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NanoCarrier Co. Ltd (2014–2025)
The table below shows the annual total assets of NanoCarrier Co. Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €4.00 Billion | -21.19% |
| 2024-03-31 | €5.07 Billion | -12.33% |
| 2023-03-31 | €5.78 Billion | -18.94% |
| 2022-03-31 | €7.14 Billion | -8.75% |
| 2021-03-31 | €7.82 Billion | -12.56% |
| 2020-03-31 | €8.94 Billion | +4.39% |
| 2019-03-31 | €8.57 Billion | +12.34% |
| 2018-03-31 | €7.63 Billion | -41.06% |
| 2017-03-31 | €12.94 Billion | -15.90% |
| 2016-03-31 | €15.39 Billion | +4.64% |
| 2015-03-31 | €14.70 Billion | +2.54% |
| 2014-03-31 | €14.34 Billion | -- |